Tishomingo Connect expands fiber network into rural Mississippi with Adtran Mosaic One
5.9.2024 14:00:00 CEST | Business Wire | Press release
News summary: Service provider required scalable fiber access technology to give more underserved customers access to reliable, high-speed internet Adtran’s Mosaic One and 10G fiber access platform enable Tishomingo Connect to scale its network rapidly and efficiently Deployment expands broadband access across rural Mississippi, supporting national efforts to close the digital divide
Adtrantoday announced that Tishomingo Connect, a subsidiary of Tishomingo County Electric Power Association (TCEPA), has deployed its Mosaic One SaaS solution to enhance rural broadband access. Leveraging Adtran’s full suite of fiber-to-the-premises and home networking technologies, Tishomingo Connect is ensuring more households and businesses can benefit from its broadband service. With Adtran’s scalable and programmable fiber access technology, the service provider can maximize its existing network investment as it expands its service area to meet the growing demand for fast and reliable internet in Northeast Mississippi. Adtran’s partner LogicomUSA is also playing a key role in the development and deployment of the new broadband network, providing technical support and ongoing NOC services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905594150/en/
Adtran’s technology is helping Tishomingo Connect deliver high-speed broadband to underserved regions of rural Mississippi. (Photo: Business Wire)
“Fiber broadband revitalizes communities and transforms lives by increasing economic activity and enabling access to services such as telehealth. That’s why we’re determined to extend the reach of our fiber network to ensure that more households and businesses in rural areas can enjoy the same high-quality broadband as those in other parts of the state,” said Cody Durham, CEO and GM of Tishomingo Connect. “By deploying Adtran’s fiber broadband technology and harnessing the support offered by its expert team, we’re expanding our network rapidly to give communities the connectivity they deserve. What’s more, with Mosaic One, we can deliver a more efficient, consistent and reliable service for all our members.”
Tishomingo Connect’s strategic investment in Adtran’s high-capacity fiber access platform ensures they can leverage extra capacity as data demand rises. With Adtran’s scalable XGS-PON OLTs and SDX Series optical network terminals, offering up to 10Gbit/s symmetrical data rates, network expansion is seamless and rapid. Additionally, Adtran’s SDG 800 Series service delivery gateways deliver high-speed Wi-Fi 6 performance, guaranteeing robust connectivity for an increasing number of household devices. Mosaic One further empowers Tishomingo Connect with actionable intelligence, enhancing subscriber experience and optimizing operations through a comprehensive view of customer interactions. AI-driven insights enable timely maintenance and reduce service disruptions, improving network reliability and cutting operating costs.
“Adtran is proud to be a partner of Tishomingo Connect as it continues its vital work of bringing fiber broadband to its members living in underserved regions of rural Mississippi,” commented John Scherzinger, GM of Americas sales at Adtran. “We have a deep understanding of the challenges and opportunities involved for electric utilities moving into the fiber broadband space. We also have the expertise, experience and technology to ensure these crucially important high-capacity rural networks are built in the most cost-effective way possible. With our Mosaic One and multigigabit fiber access solutions, Tishomingo has a seamless and cost-effective upgrade path to offering even more capable services in the future.”
“We support the work of electric cooperative subsidiaries like Tishomingo Connect to increase broadband connectivity in regions long overlooked by other service providers. That’s why we’re proud to offer a range of value-added services that ensure more rural subscribers can take advantage of a fast and reliable internet connection,” noted Noah Southerland, CEO of LogicomUSA. “Our technology and comprehensive support services are designed to minimize costs and time without compromising quality. This makes it easier for Tishomingo Connect to deploy and manage its broadband network, and it also means end-users benefit from high-quality connectivity they can always rely on.”
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
Published by
ADTRAN Holdings, Inc.
www.adtran.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905594150/en/
Contacts
For media
For media
Gareth Spence
+44 1904 699 358
public.relations@adtran.comFor investors
Rhonda Lambert
+1 256 963 7450
investor.relations@adtran.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom